Entre las marcas de nuestros más de 25 colaboradores destaca TargetMol
We have reached an agreement with TargetMol: CymitQuimica clients will benefit for a 20% discount on all TargetMol products until the end of the year.On our website you can find the products offered by this partner, which has become one of the world's most recognised compound libraries and small molecule inhibitors supplier. TargetMol offers approximately 120 compound libraries and a wide range of chemical products and kits for life sciences.
Termina el 31 dic( quedan 8 días )
GSK5852
GSK5852, an HCV NS5B inhibitor, has IC50 of 50 nM; potently fights HCV with EC50 of 3.0 nM for GT1a and 1.7 nM for GT1b.Fórmula:C27H27BF2N2O6SForma y color:SolidPeso molecular:556.39HBV-IN-19 TFA
CAS:<p>HBV-IN19 TFA suppresses HBsAg, hampers HBV infection, and aids in HBV research.</p>Fórmula:C26H31F3N2O8Forma y color:SolidPeso molecular:556.53AChE-IN-20
CAS:AChE-IN-20: AChE inhibitor (IC50: 397.32 nM), hCA-I/II blocker (IC50: ~77 nM avg), α GLY suppressor (IC50: 52.08 nM).Fórmula:C22H20N8O6S2Forma y color:SolidPeso molecular:556.57JBJ-09-063
CAS:JBJ-09-063: EGFR inhibitor, IC50s 0.147-0.396 nM for various mutants; hinders EGFR/Akt/ERK1/2 phosphorylation; targets TKI-sensitive/resistant lung cancer.Fórmula:C31H29FN4O3SForma y color:SolidPeso molecular:556.65AS-604850
CAS:AS-604850: ATP-competitive PI3Kγ inhibitor, IC50 250 nM, 18x > PI3Kα, 80x > PI3Kδ/β.Fórmula:C11H5F2NO4SPureza:99.65%Forma y color:SolidPeso molecular:285.22B026
CAS:<p>B026: Oral p300/CBP HAT inhibitor, IC50: p300 1.8 nM, CBP 9.5 nM; targets AR+ prostate cancer cells.</p>Fórmula:C27H23F4N5O4Forma y color:SolidPeso molecular:557.5α-Glycosidase-IN-1
CAS:α-Glycosidase-IN-1 (compound MZ7) is a potent inhibitor of α-GLY (α-glycosidase) (IC50: 44.72 nM, Ki: 44.74 nM).Fórmula:C21H19N9O6S2Forma y color:SolidPeso molecular:557.56WNY1613
CAS:<p>WNY1613: Potent PI3Kδ inhibitor with anti-NHL properties, induces apoptosis in cells, affects phosphorylation in vitro/in vivo.</p>Fórmula:C29H35N9O3Forma y color:SolidPeso molecular:557.65COX-2-IN-10
COX-2-IN-10 is a potent COX-2 inhibitor, reducing IL-6, TNF-α, IL-1β, PGE2 (IC50=2.54 μM), and iNOS expression.Fórmula:C31H32FN5O2SForma y color:SolidPeso molecular:557.684BAB
CAS:4BAB (compound 29) is an irreversible inhibitor of glyoxalase I (GLO1) and exhibits anticancer activity.Fórmula:C18H28BrN3O10SForma y color:SolidPeso molecular:558.4Antitubercular agent-19
CAS:Antitubercular agent-19: effective against MTB H37Rv/MDR strains (MIC <0.016μg/ml), low cytotoxicity, high acute toxicity in BALB/c mice.Fórmula:C24H20F6N4O3SForma y color:SolidPeso molecular:558.5Cap-dependent endonuclease-IN-14
CAS:Cap-dependent endonuclease-IN-14 hinders CEN and could treat influenza virus infections. (Patent CN113620948A, compound 1-c).Fórmula:C30H23FN2O6SForma y color:SolidPeso molecular:558.58GRPR antagonist-1
GRPR antagonist-1 targets GRPR, kills specific cancer cells (e.g., PC3, Pan02, HGC-27), and promotes apoptosis by modulating Bcl-2 and Bax.Fórmula:C29H33F3N4O4Forma y color:SolidPeso molecular:558.59PD-1/PD-L1-IN-16
PD-1/PD-L1-IN-16 is a potent inhibitor of PD-1/PD-L1 (IC50: 53.2 nM) and has shown research potential for tumour immunotherapy.Fórmula:C34H30N4O4Forma y color:SolidPeso molecular:558.63HIV-1 protease-IN-2
CAS:HIV-1 protease-IN-2: strong HIV-1 protease blocker, IC50 2.53 nM, fights DRV-sensitive/resistant HIV-1.Fórmula:C27H34N4O7SForma y color:SolidPeso molecular:558.65Astragaloside A
CAS:Astragaloside A, saponin from Astragalus membranaceus, treats cardiovascular diseases.Fórmula:C41H68O14Pureza:99.87% - 99.94%Forma y color:White PowderPeso molecular:784.97SARS-CoV-2-IN-19
CAS:"SARS-CoV-2-IN-19: potent SARS-CoV-2 decapping enzyme inhibitor, EC50 8.8 μM, potential for HCoV outbreaks."Fórmula:C33H38N2O6Forma y color:SolidPeso molecular:558.66ZINC000104379474
ZINC000104379474 is a compound that targets SARS-CoV-2 endoribonuclease.Fórmula:C27H33N3O10Forma y color:SolidPeso molecular:559.57GRPR antagonist-2
GRPR antagonist-2 blocks GRPR, kills some cancer cells, effective on HGC-27 (IC50: 0.77 μM) & Pan02 (IC50: 2.5 μM).Fórmula:C28H32F3N5O4Forma y color:SolidPeso molecular:559.58CYP3A4-IN-1
CAS:CYP3A4-IN-1 is a potent inhibitor of cytochrome P450 3A4 (CYP3A4) (IC50: 0.085 μM).Fórmula:C31H37N5O3SForma y color:SolidPeso molecular:559.72MU1656
CAS:<p>MU1656 is a selective inhibitor of histone methyltransferase DOT1L, which significantly inhibits cancer cell proliferation in hematological malignancies.</p>Fórmula:C32H45N7O2Pureza:96.92%Forma y color:SolidPeso molecular:559.75OP-5244 sodium
OP-5244 sodium: potent oral CD73 inhibitor (IC50: 0.25 nM), potential in cancer research by hindering adenosine, reversing immunosuppression.Fórmula:C19H28ClN5NaO9PForma y color:SolidPeso molecular:559.87PI3K-IN-29
CAS:<p>PI3K-IN-29: Strong PI3K block, inhibits Akt phosphorylation. IC50: U87MG 0.264µM, HeLa 2.04µM, HL60 1.14µM.</p>Fórmula:C27H22ClN7O3SForma y color:SolidPeso molecular:560.03BLK-IN-1
CAS:<p>BLK-IN-1 selectively blocks BLK and BTK with IC50s of 18.8 and 20.5 nM, used in cancer research.</p>Fórmula:C29H23F3N6O3Forma y color:SolidPeso molecular:560.53(R)-(-)-Gossypol acetic acid
CAS:<p>(R)-(-)-Gossypol acetic acid binds Bcl-2, Bcl-xL, Mcl-1 (Ki: 0.32, 0.48, 0.18 μM); no BIR3/BID inhibition. Phase 2.</p>Fórmula:C30H30O8·C2H4O2Pureza:98.88% - 99.5%Forma y color:SolidPeso molecular:578.61A3AR antagonist 1
CAS:<p>A3AR antagonist 1 is a potent and selective human A3adenosine receptor (AR) antagonist (Ki: 4.63) and has no affinity for the rat A3AR.</p>Fórmula:C32H24N4O4SForma y color:SolidPeso molecular:560.62ACC1/2-IN-1
CAS:ACC1/2-IN-1 is a potent inhibitor of ACC1/2 and acts on ACC1 (IC50: 98.06 nM) and ACC2 (IC50: 29.43 nM). ACC1/2-IN-1 can be used in cancer research.Fórmula:C34H32N4O4Forma y color:SolidPeso molecular:560.64HIV-1 inhibitor-29
CAS:HIV-1 inhibitor-29: Blocks HIV-1 IIIB (EC50: 2.18μM), resists F227L/V106A (EC50: 0.974μM), low toxicity (CC50: 211μM), for AIDS research.Fórmula:C30H36N6O5Forma y color:SolidPeso molecular:560.64HIV-1 inhibitor-14
<p>HIV-1 inhibitor-14: potent, broad HIV-1 RT inhibitor. IC50=0.14μM. Effective against wild-type and resistant strains, EC50=5.79-28.3nM.</p>Fórmula:C29H32N6O4SForma y color:SolidPeso molecular:560.67DPP-4/GPR119 modulator 2
CAS:DPP-4/GPR119 modulator 2 is an inhibitor of dipeptidyl peptidase IV (DPP-IV) (IC50: 0.22 μM) and an agonist of GPR119 (EC50: 0.95 μM).Fórmula:C30H40N8O3Forma y color:SolidPeso molecular:560.69Bepotastine tosylate
CAS:Bepotastine tosylate: Oral 2nd-gen H1 antagonist, inhibits histamine effects on NGF; treats conjunctivitis, urticaria.Fórmula:C28H33ClN2O6SForma y color:SolidPeso molecular:561.09BMS-986141
CAS:<p>BMS-986141(UDM-003183) is a selective and potent protease-activated receptor-4 (PAR-4) antagonist with oral activity and an IC50 value of 0.4 nM.BMS-98614</p>Fórmula:C27H23N5O5S2Pureza:98.43% - 99.26%Forma y color:SolidPeso molecular:561.63Multi-kinase-IN-2
CAS:Orally active Multi-kinase-IN-2 blocks angiokinases including VEGFR, PDGFR, FGFR, and more, reducing AKT/ERK phosphorylation and promoting apoptosis.Fórmula:C34H35N5O3Forma y color:SolidPeso molecular:561.67AZ14145845
AZ14145845 is an in vivo potent and highly selective type I1/2 Mer/Axl bispecific kinase inhibitor.Fórmula:C32H35N9OForma y color:SolidPeso molecular:561.68SM-433
CAS:<p>SM-433: Smac mimetic, blocks IAPs, strong XIAP BIR3 affinity (IC50 <1 μM). See patent WO2008128171A2.</p>Fórmula:C32H43N5O4Forma y color:SolidPeso molecular:561.71Atracurium besylate
CAS:Atracurium besylate (51W89) is a short-acting, non-depolarizing muscle relaxant, not affecting the heart or reliant on kidneys.Fórmula:C65H82N2O18S2Pureza:98.94% - 99.71%Forma y color:SolidPeso molecular:1243.49EZH2-IN-11
CAS:EZH2-IN-11, a potent E2HZ inhibitor with potential for cancer treatment, is highlighted in patent WO2019204490A1.Fórmula:C28H36ClN3O5SForma y color:SolidPeso molecular:562.12Canocapavir
CAS:Canocapavir (ZM-H1505R) is an HBV coat protein modulator with antiviral activity for the treatment of hepatitis B virus.Fórmula:C27H21BrFN5O3Pureza:98.4% - 98.40%Forma y color:SolidPeso molecular:562.39hCA I-IN-2
CAS:hCA I-IN-2 (6d) inhibits hCA I (Ki: 18.8 nM) more selectively over II, IX, XII (Ki: 375.1, 1721, 283.9 nM).Fórmula:C26H20BrN5O3SForma y color:SolidPeso molecular:562.44hCAXII-IN-3
CAS:hCAXII-IN-3 (Compound 6o) is a selective inhibitor of human carbonic anhydrase XII (hCAXII) (Ki: 10.0 nM).Fórmula:C26H20BrN5O3SForma y color:SolidPeso molecular:562.44MAT2A-IN-1
CAS:MAT2A-IN-1 suppresses MAT2A, key for MTAP-deficient cancer cell growth; studied for gastric, colon, liver, pancreatic cancers.Fórmula:C29H28F2N6O4Forma y color:SolidPeso molecular:562.57AZ13824374
AZ13824374: potent, selective ATAD2 inhibitor; anti-proliferative in breast cancer; pIC50: FRET 8.2, NanoBRET 6.2.Fórmula:C30H39FN8O2Forma y color:SolidPeso molecular:562.68GSK3739936
CAS:<p>GSK3739936 inhibits HIV-1 integrase (IC50: 11.1 nM, EC50: 1.7 nM), weak on CYP (IC50 >24.3 μM), rapid absorption, moderate clearance, high oral availability.</p>Fórmula:C34H43FN2O4Forma y color:SolidPeso molecular:562.71FAK-IN-2
FAK-IN-2: potent oral FAK inhibitor, IC50 35 nM, reduces tumor growth, migration, and induces cell death.Fórmula:C28H31ClN8O3Forma y color:SolidPeso molecular:563.05Ziprasidone mesylate trihydrate
CAS:<p>Ziprasidone mesylate hydrate is an oral 5-HT/D2 antagonist with Ki: D2=4.8nM, 5-HT2A=0.42nM, 5-HT1A=3.4nM in rats.</p>Fórmula:C22H31ClN4O7S2Forma y color:SolidPeso molecular:563.08Azaperone
CAS:Azaperone, a sedative and antiemetic veterinary tranquilizer, belongs to pyridinylpiperazine and butyrophenone classes.Fórmula:C19H22FN3OPureza:98.73%Forma y color:White Or Off-White CrystallinePeso molecular:327.4BODIPY FL prazosin
CAS:<p>BODIPY FL prazosin is an α1-adrenergic antagonist that inhibits α1a-AR and α1b-AR.</p>Fórmula:C28H32BF2N7O3Pureza:97.27%Forma y color:SolidPeso molecular:563.41Cap-dependent endonuclease-IN-17
CAS:<p>CEN inhibitor IN-17 targets influenza A/H3N2; IC50: 1.29 μM. From patent CN112898346A, DSC701.</p>Fórmula:C24H20F2N3O7PSForma y color:SolidPeso molecular:563.47Anticancer agent 50
CAS:Anticancer agent 50 targets ABCB1 pump, has cytotoxic effects, alters cyclin D1/p53, and shows promise in T lymphoma research.Fórmula:C30H32N2O4SeForma y color:SolidPeso molecular:563.55PF-3758309 dihydrochloride
PF-3758309 dihydrochloride is a potent PAK4 inhibitor (Kd = 2.7 nM, Ki = 18.7 nM), oral, ATP-competitive; blocks cell growth, induces apoptosis.Fórmula:C25H32Cl2N8OSForma y color:SolidPeso molecular:563.55Trimetrexate glucuronate
CAS:Trimetrexate glucuronate, a folic acid foe, blocks DNA/RNA synthesis by inhibiting purine and thymidylic acid production, may fight tumors.Fórmula:C25H33N5O10Forma y color:SolidPeso molecular:563.564SAP2-IN-1
CAS:SAP2-IN-1 inhibits secreted aspartate protease 2 (IC50: 0.92 μM), doesn't work in vitro, and helps research infections.Fórmula:C34H29NO7Forma y color:SolidPeso molecular:563.6Keap1-Nrf2-IN-14
CAS:<p>Keap1-Nrf2-IN-14, a KEAP1-NRF2 inhibitor (IC50: 75 nM, Kd: 24 nM), boosts NRF2 gene expression, antioxidative and anti-inflammatory response.</p>Fórmula:C30H29NO8SForma y color:SolidPeso molecular:563.62(Rac)-OSMI-1
(Rac)-OSMI-1, a racemate, inhibits OGT (IC50: 2.7 μM) affecting O-GlcNAcylation without changing surface glycans.Fórmula:C28H25N3O6S2Forma y color:SolidPeso molecular:563.64LXRβ agonist-3
CAS:LXRβ agonist-3 is a potent and selective LXRβ (liver X receptor β) agonist (EC50: 0.095 μM).Fórmula:C30H33N3O6SForma y color:SolidPeso molecular:563.66AZD1981
CAS:AZD1981: selective CRTh2 antagonist, IC50 4 nM, 1000x specificity over 340+ enzymes/receptors, tested in asthma and other trials.Fórmula:C19H17ClN2O3SPureza:98.87% - 99.67%Forma y color:SolidPeso molecular:388.87AChE-IN-12
CAS:AChE-IN-12 inhibited rat/eel AChE, crossed BBB, prevented Aβ1-42 aggregation, and has potential for Alzheimer's research.Fórmula:C33H41NO7Forma y color:SolidPeso molecular:563.68BRD4/CK2-IN-1
CAS:<p>BRD4/CK2-IN-1 is a small-molecule inhibitor targeting BRD4 and CK2, inducing apoptosis and autophagy-related cell death.</p>Fórmula:C29H30ClN5O5Pureza:99.02%Forma y color:SolidPeso molecular:564.03KS100
CAS:KS100 inhibits ALDH1A1, ALDH2, ALDH3A1, boosts ROS, triggers apoptosis, and has anti-cancer properties.Fórmula:C17H14Br3N3O2SPureza:97.05%Forma y color:SolidPeso molecular:564.09SHP2 inhibitor LY6
CAS:<p>SHP2 inhibitor LY6 (LY6) is a potent and selective SHP2 inhibitor (IC50: 9.8 μM) that blocks SHP2-mediated cell signaling and proliferation.</p>Fórmula:C30H27Cl2N3O4Forma y color:SolidPeso molecular:564.46MMP-9-IN-4
CAS:<p>MMP-9-IN-4 inhibits MMP-9 (IC50=7.46nM) and AKT (IC50=8.82nM), induces apoptosis and is used in cancer research.</p>Fórmula:C28H19F3N4O6Forma y color:SolidPeso molecular:564.47BuChE-IN-2
CAS:BuChE-IN-2 inhibits BuChE (IC50: 1.28 μM), NO (0.67 μM), Aβ, ROS, chelates Cu2+, penetrates BBB, used in Alzheimer's research.Fórmula:C28H20F4N6O3Forma y color:SolidPeso molecular:564.49EGFR-IN-50
CAS:EGFR-IN-50, a potent EGFR blocker, hinders L858R mutation; GI50: 8 nM for TEL-EGFR-L858R, 6.03 μM for T790M-L858R; curbs cancer cell growth.Fórmula:C24H26BrN3O4S2Forma y color:SolidPeso molecular:564.51Mitoxantrone diacetate
CAS:<p>Mitoxantrone diacetate hinders topoisomerase II & PKC, fights tumors & orthopoxviruses (IC50: 8.5μM, EC50: 0.25-0.8μM).</p>Fórmula:C26H36N4O10Forma y color:SolidPeso molecular:564.592(E/Z)-Zotiraciclib citrate
(E/Z)-Zotiraciclib ((E/Z)-TG02) citrate is a potent inhibitor of CDK2, JAK2 and FLT3 and can be used in cancer research.Fórmula:C29H32N4O8Forma y color:SolidPeso molecular:564.59GLP-1R agonist 8
CAS:<p>GLP-1R agonist 8 is a potent agonist of GLP-1R (EC50 < 2 nM).</p>Fórmula:C33H32N4O5Forma y color:SolidPeso molecular:564.63AZD3514
CAS:<p>AZD3514 is a potent and oral androgen receptor downregulator with Ki of 2.2 μM and has ability of reducing AR protein expression.Phase 1.</p>Fórmula:C25H32F3N7O2Pureza:98.09%Forma y color:SolidPeso molecular:519.56MRTX-EX185
<p>MRTX-EX185 inhibits GDP-KRAS/G12D; IC50=90 nM on G12D. It also binds GDP-HRAS.</p>Fórmula:C33H33FN6O2Forma y color:SolidPeso molecular:564.65MAP855
CAS:MAP855: potent, selective, oral MEK1/2 inhibitor; IC50=3 nM, pERKEC50=5 nM; effective on wild-type/mutant MEK1/2.Fórmula:C28H23ClF2N6O3Forma y color:SolidPeso molecular:564.97Anticancer agent 61
CAS:Anticancer agent 61, an oral drug, inhibits HepG2, Bel-7402, MCF-7 cell growth; IC50: 1.12, 1.97, 1.08 μM respectively. Stops tumor growth.Fórmula:C22H22N3Na2O8PSForma y color:SolidPeso molecular:565.45HER2-IN-7
CAS:HER2-IN-7 is a potent HER2 inhibitor with potential for researching ErbB-related diseases, especially cancer.Fórmula:C28H26F3N7O3Forma y color:SolidPeso molecular:565.55DX3-234
CAS:DX3-234 is a OXPHOS inhibitor that acts by inhibiting complex I in the mitochondrial ETC,for cancers dependent on aerobic metabolism, such as pancreatic cancer.Fórmula:C25H35N5O6S2Pureza:98.96%Forma y color:SolidPeso molecular:565.71PDE4B-IN-3
PDE4B-IN-3 is a potent inhibitor of PDE4B (IC50: 0.94 μM) and exhibits anti-inflammatory effects.Fórmula:C30H35N3O4S2Forma y color:SolidPeso molecular:565.75Lipid-lowering agent-1
CAS:Lipid-lowering agent-1 reduces LDLC and boosts HDLC, effectively cutting fat in high-fat diet rats.Fórmula:C26H19ClF3NO6SForma y color:SolidPeso molecular:565.94GLP-1R agonist 10
CAS:GLP-1R agonist 10 is a GLP-1 agonist (EC50: 0.051 nM).Fórmula:C29H29ClFN5O4Forma y color:SolidPeso molecular:566.02Thi-DPPY
CAS:Thi-DPPY: Potent JAK3/BTK inhibitor (IC50: 1.38/62.4 nM), anti-proliferative, anti-inflammatory, potential in IPF research.Fórmula:C28H28ClN5O4SForma y color:SolidPeso molecular:566.07HIV-1 inhibitor-23
CAS:HIV-1 inhibitor-23 suppresses HIV reverse transcriptase, effective on wild-type (EC50: 24.9 nM) and K103N mutant (EC50: 10.4 nM), with in vitro stability.Fórmula:C30H26N6O4SForma y color:SolidPeso molecular:566.63Azithromycin
CAS:<p>Azithromycin (CP 62993) is a macrolide antibiotic that primarily targets the 50S subunit of bacterial ribosomes. High-Quality, Low-Cost!</p>Fórmula:C38H72N2O12Pureza:99.9% - 99.97%Forma y color:White To Off-White Solid CrystallinePeso molecular:748.98ABN401
CAS:ABN401: potent c-MET inhibitor (IC50: 10 nM), cytotoxic to MET-dependent cancers, blocks tumor c-MET phosphorylation, for cancer research.Fórmula:C29H34N12OForma y color:SolidPeso molecular:566.66GSK1820795A
CAS:<p>GSK1820795A: Telmisartan analog, selective hGPR132a antagonist, blocks yeast activation by N-acylamides, angiotensin II antagonist, partial PPARγ agonist.</p>Fórmula:C35H34N8Forma y color:SolidPeso molecular:566.7DNA gyrase B-IN-1
DNA gyrase B-IN-1, a potent inhibitor of P. aeruginosa DNA gyrase B, has IC50 of 2.2 μM with high affinity and stability.Fórmula:C23H18ClF3N6O4SForma y color:SolidPeso molecular:566.94RPT193
CAS:RPT193 is an oral CCR4 inhibitor reducing Th2 cell migration in atopic dermatitis, asthma, and allergies.Fórmula:C27H34Cl3N5O2Forma y color:SolidPeso molecular:566.95Antitumor agent-58
<p>Antitumor agent-58 suppresses tumor growth, colony formation, cell migration, and induces mitochondrial dysfunction in MGC-803 cells.</p>Fórmula:C27H28F3N9SForma y color:SolidPeso molecular:567.63FGFR4-IN-6
FGFR4-IN-6: covalent, reversible FGFR4 blocker, 5.4 nM IC50, good oral bioavailability, reduces Hep3B2.1-7 tumors in mice, low toxicity.Fórmula:C31H33N7O4Forma y color:SolidPeso molecular:567.64WS-898
<p>WS-898 boosts paclitaxel efficacy in resistant cells by inhibiting ABCB1; IC50: SW620/Ad300 - 5.0 nM, KB-C2 - 3.67 nM, HEK293/ABCB1 - 3.68 nM.</p>Fórmula:C33H25N7OSForma y color:SolidPeso molecular:567.66RORγt agonist 3
CAS:RORγt agonist 3 is a potent agonist of RORγt.Fórmula:C34H37N3O3SForma y color:SolidPeso molecular:567.74Anti-inflammatory agent 23
Anti-inflammatory agent 23 blocks LPS-induced NO (IC50: 0.449 μM) and binds p65 well.Fórmula:C34H49NO6Forma y color:SolidPeso molecular:567.76ZM514
<p>ZM514 inhibits CD73 (hCD73 IC50: 1.39 μM, mCD73 IC50: 14.65 μM) with low cytotoxicity, suitable for cancer research.</p>Fórmula:C36H57NO4Forma y color:SolidPeso molecular:567.84Azomycin
CAS:Azomycin (Ro 05-9129) is an antimicrobial antibiotic produced by a strain of Nocardia mesenterica.Fórmula:C3H3N3O2Pureza:≥95%Forma y color:Yellow Orange PowderPeso molecular:113.07EGFR-IN-17
<p>EGFR-IN-17: potent, selective EGFR inhibitor, IC50 of 0.2 nM, overcomes C797S drug resistance.</p>Fórmula:C27H31ClN7O3PForma y color:SolidPeso molecular:568.01GDC-6036-NH
CAS:<p>GDC-6036-NH is a precursor of compound 17a /b, which is a RAS inhibitor that can be used in cancer research.</p>Fórmula:C26H30ClF4N7OPureza:99.84%Forma y color:SolidPeso molecular:568.01Antitumor agent-37
Antitumor agent-37: strong anti-growth, anti-spread, induces DNA damage, apoptosis via Bcl-2/Bax/caspase3, boosts immune response.Fórmula:C16H18Cl2N2O4PtForma y color:SolidPeso molecular:568.32Glyoxalase I inhibitor 4
CAS:Glyoxalase I inhibitor 4 is a potent inhibitor of glyoxalase I (GLO1) (Ki: 10 nM).Fórmula:C17H21IN4O8SForma y color:SolidPeso molecular:568.34Dopamine D3 receptor antagonist-1
<p>Dopamine D3 receptor antagonist-1 is a dopamine D3 receptor selective or multi-targeting ligand with a Ki value of 1.58 nM that has demonstrated therapeutic</p>Fórmula:C31H35Cl2N3O3Forma y color:SolidPeso molecular:568.53Top/HDAC-IN-2
Top/HDAC-IN-2 (45b) is a dual inhibitor of Top and HDAC that induces apoptosis and exhibits significant anti-tumour effects.Fórmula:C30H32N8O4Forma y color:SolidPeso molecular:568.63ERα antagonist 1
CAS:<p>ERα antagonist 1 is a selective, potent, covalent estrogen receptor alpha (ERα) antagonist that blocks the cell cycle of MCF-7 cells in G0/G1 phase and induces</p>Fórmula:C33H32N2O5SForma y color:SolidPeso molecular:568.68ALK-IN-23
ALK-IN-23 inhibits ALK (IC50: 1.6-0.71 nM), hinders cancer cell spread, forms colonies in vitro, and reduces tumors in mice with low toxicity.Fórmula:C26H29ClN8O3SForma y color:SolidPeso molecular:569.08Iruplinalkib
CAS:Iruplinalkib (WX-0593) is an orally active, selective and potent ALK and ROS1 tyrosine kinase inhibitor with anticancer activity for use in the study of non-small cell lung cancer.Fórmula:C29H38ClN6O2PPureza:97.38% - 99.29%Forma y color:SolidPeso molecular:569.08Antifungal agent 42
Antifungal 42 blocks biofilm formation and inhibits C.albicans' CYP51.Fórmula:C22H20Cl2N4Se2Forma y color:SolidPeso molecular:569.25Siponimod
CAS:Siponimod (BAF312) modulates S1P1/S1P5 with EC50s of 0.39/0.98 nM; >1000x selectivity over S1P2-4.Fórmula:C29H35F3N2O3Pureza:99.13% - 99.8%Forma y color:SolidPeso molecular:516.59
